Session 3: AI & Imaging: Innovative insights into next generation therapeutics and diagnostics

Tuesday, 3rd December 12.15PM AEST | Plenary session

A 20-minute keynote presentation, followed by a Q&A session focused on the transformative potential for research infrastructure of generative, advanced imaging, and other AI-driven imaging techniques. The keynote will explore how these innovations are revolutionizing precision health, enhancing the accuracy and efficiency of medical diagnostics, and facilitating personalized treatment plans.

It will delve into the implications for research translation, emphasizing the critical role of multidisciplinary RIs in supporting these advancements. Additionally, the session will address the policy considerations surrounding the integration of these technologies, including ethical guidelines, data privacy concerns, and the need for regulatory frameworks. Join us to explore the future of AI in healthcare and its broader societal impact.

Keynote Speaker

Professor Jan Ellenberg is the Director of SciLifeLab, Sweden. He is distinguished for his many contributions to the cell biology and imaging field, mainly through his position as Senior Scientist and Head of the Cell Biology and Biophysics Unit at the European Molecular Biology Laboratory (EMBL). Professor Ellenberg develops and automates quantitative 4D imaging, single molecule spectroscopy, as well as light sheet and super-resolution microscopy, to obtain structural and functional measures of the molecular machinery inside cells. 

Moderator

Ian Smith has a background in both industry and research and up until 2020, was Vice-Provost at Monash University. In this leadership role, he had responsibility for research strategy, infrastructure and alliances.  Ian is now Professor Emeritus and consults for academic, government and industry organisations; he is a board director and chair of several national and international senior government and non-government governing and advisory boards.